About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
When it comes to assessing the value of medicines, conventional cost-effectiveness analysis (CEA) methods typically only account for the value of quality-adjusted life years (QALYs) and health care costs and miss important elements of value that matter to patients and society. The outcomes that matter to patients should matter to everyone.
Value Assessments Should Include All the Outcomes That Matter to Patients and Families image
Fact Sheet
Cost and Value
Value Assessments Should Include All the Outcomes That Matter to Patients and Families
Value Assessments Should Include All the Outcomes That Matter to Patients and Families image